AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22201688 — intervention group
Group type: COMPARATOR
Intervention: Artificial turf pitch surface
Number of subjects: 22
Study 20608923 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium mixed with sodium bicarbonate 8.4%
Number of subjects: 120
Study 20608923 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium mixed with isotonic saline
Number of subjects: 120
Study 17509350 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine (1 mg twice daily) with behavioral modification
Number of subjects: 72
Study 17509350 — intervention group
Group type: COMPARATOR
Intervention: Behavioral modification only
Number of subjects: 72
Study 17509350 — intervention group
Group type: COMPARATOR
Intervention: Behavioral modification plus placebo
Number of subjects: 72
Study 16055817 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 547
Study 16055817 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 547
Study 12161484 — intervention group
Group type: EXPERIMENTAL
Intervention: raloxifene 60 mg/d
Number of subjects: 7705
Study 12161484 — intervention group
Group type: EXPERIMENTAL
Intervention: raloxifene 120 mg/d
Number of subjects: 7705
Study 12161484 — intervention group
Group type: EXPERIMENTAL
Intervention: raloxifene 60 mg/d and 120 mg/d
Number of subjects: 7705
Study 10102544 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion program providing social support and psychoeducational intervention with positive reframing psychotherapeutic maneuver
Number of subjects: 28
Study 8700340 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 300 mg/day for 12 weeks with hypocaloric diet
Number of subjects: 12
Study 8700340 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric diet only (Control)
Number of subjects: 12
Study 8700340 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose 300 mg/day
Number of subjects: 12
Study 1810616 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (group A)
Number of subjects: 90
Study 1810616 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment with long-leg plaster (group B)
Number of subjects: 90
Study 6622929 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone plus azathioprine 50 mg daily
Number of subjects: 204
Study 6622929 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 100 mg daily
Number of subjects: 204
Study 6622929 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (Dutimelan 8 15)
Number of subjects: 204
Study 6622929 — intervention group
Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 204
Study 31858966 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced motivational interviewing (MI) with behaviour change techniques (BCTs) delivered in group format
Number of subjects: 1742
Study 31858966 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced motivational interviewing (MI) with behaviour change techniques (BCTs) delivered in individual format
Number of subjects: 1742
Study 31858966 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1742
Study 30132529 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine (2 g/day for 16 weeks)
Number of subjects: 43
Study 30132529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 27916140 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (2 cans of beer, 660 mL, ∼26 g alcohol)
Number of subjects: 24
Study 27916140 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-free beer consumption (control)
Number of subjects: 24
Study 25076468 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial pupil contact lens
Number of subjects: 38
Study 25076468 — intervention group
Group type: COMPARATOR
Intervention: Contralateral balanced multifocal contact lens combination (CBMCLC)
Number of subjects: 38
Study 22402677 — intervention group
Group type: EXPERIMENTAL
Intervention: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Number of subjects: 168
Study 22402677 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Outcome Survey activities of daily living subscale (KOS‐ADL)
Number of subjects: 168
Study 22402677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Extremity Functional Scale (LEFS)
Number of subjects: 168
Study 22402677 — intervention group
Group type: EXPERIMENTAL
Intervention: All three outcome measures (WOMAC, KOS‐ADL, LEFS)
Number of subjects: 168
Study 19470315 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief strategic family therapy (BSFT)
Number of subjects: 0
Study 19470315 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 16887281 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management plus methadone maintenance
Number of subjects: 690
Study 16887281 — intervention group
Group type: COMPARATOR
Intervention: THC nonreporters
Number of subjects: 690
Study 14977155 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based curriculum
Number of subjects: 3
Study 14977155 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counselor meetings
Number of subjects: 3
Study 14977155 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 3
Study 10882149 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical etidronate therapy
Number of subjects: 107
Study 10882149 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 107
Study 9376205 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral skills training HIV risk reduction intervention (4 sessions)
Number of subjects: 81
Study 9376205 — intervention group
Group type: COMPARATOR
Intervention: HIV risk education and sensitization control condition (4 sessions)
Number of subjects: 81
Study 8229487 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosurf Neonatal
Number of subjects: 617
Study 8229487 — intervention group
Group type: COMPARATOR
Intervention: Survanta
Number of subjects: 617
Study 3536258 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 118
Study 3536258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 2901181 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg once daily of methimazole
Number of subjects: 54
Study 2901181 — intervention group
Group type: COMPARATOR
Intervention: 10 mg 3 times daily of methimazole
Number of subjects: 54
Study 2901181 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study 31694478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 72
Study 31694478 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based intervention
Number of subjects: 72
Study 30226991 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH EC intervention
Number of subjects: 365
Study 30226991 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 365
Study 28355359 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive cycle ergometer exercise for 20 minutes at 30 cycles/min
Number of subjects: 19
Study 28355359 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapeutic intervention)
Number of subjects: 19
Study 25182412 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tVNS (transcutaneous vagus nerve stimulation) administered at left external acoustic meatus for 60 min
Number of subjects: 10
Study 25182412 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation at left ear lobe for 60 min
Number of subjects: 10
Study 23491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary dissection
Number of subjects: 933
Study 23491275 — intervention group
Group type: COMPARATOR
Intervention: No axillary dissection
Number of subjects: 933
Study 21575032 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 μg TTX (given t.i.d.)
Number of subjects: 216
Study 21575032 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg TTX (given t.i.d.)
Number of subjects: 216
Study 21575032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z250 at 24 hours
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z250 at 6 months
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Charisma at 24 hours
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Charisma at 6 months
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Charisma subsurface hardness at 6 months
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z250 subsurface hardness at 6 months
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Both composites at 6 months
Number of subjects: 2
Study 18266654 — intervention group
Group type: EXPERIMENTAL
Intervention: Both composites surface roughness
Number of subjects: 2
Study 16436148 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge (DBPCFC) after prolonged cow's milk elimination diet
Number of subjects: 11
Study 16436148 — intervention group
Group type: EXPERIMENTAL
Intervention: Accidental ingestion of cow's milk during elimination diet
Number of subjects: 11
Study 16436148 — intervention group
Group type: COMPARATOR
Intervention: Prolonged cow's milk elimination diet
Number of subjects: 11
Study 14499444 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical morphine mouthwash (2 per thousand solution)
Number of subjects: 32
Study 14499444 — intervention group
Group type: COMPARATOR
Intervention: Topical morphine mouthwash (1 per thousand solution)
Number of subjects: 32
Study 10872650 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg ibuprofen lysine
Number of subjects: 17
Study 9195171 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine 40 ml (200 mg)
Number of subjects: 131
Study 9195171 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine 40 ml (100 mg)
Number of subjects: 131
Study 9195171 — intervention group
Group type: COMPARATOR
Intervention: Saline 40 ml
Number of subjects: 131
Study 1287837 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous bupivacaine infusion
Number of subjects: 80
Study 1287837 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 80
Study 1287837 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control) in patients with COAD
Number of subjects: 80
Study 1287837 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous bupivacaine infusion in patients with COAD
Number of subjects: 80
Study 1287837 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (Control) in patients without COAD
Number of subjects: 80
Study 4040887 — intervention group
Group type: EXPERIMENTAL
Intervention: pafenolol 25 mg
Number of subjects: 31
Study 4040887 — intervention group
Group type: EXPERIMENTAL
Intervention: pafenolol 50 mg
Number of subjects: 31
Study 4040887 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study 30262297 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-distance runners (athletes)
Number of subjects: 47
Study 30262297 — intervention group
Group type: COMPARATOR
Intervention: Untrained students (controls)
Number of subjects: 47
Study 27181367 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Appliance (OA) therapy
Number of subjects: 14
Study 27181367 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline passive upper-airway collapsibility and loop gain
Number of subjects: 14
Study 24418351 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative yoga
Number of subjects: 180
Study 24418351 — intervention group
Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 180
Study 22670258 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil-containing mouthrinse (EO)
Number of subjects: 408
Study 22670258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride-containing mouthrinse (CPC)
Number of subjects: 408
Study 22670258 — intervention group
Group type: COMPARATOR
Intervention: Negative control rinse
Number of subjects: 408
Study 20181302 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 to 40 mg per day plus IPT adapted to BPD (IPT-BPD)
Number of subjects: 55
Study 20181302 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20 to 40 mg per day plus clinical management
Number of subjects: 55
Study 19060514 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular sodium hyaluronate injections (Orthovisc)
Number of subjects: 67
Study 19060514 — intervention group
Group type: COMPARATOR
Intervention: Control group (only follow-up)
Number of subjects: 67
Study 15951715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 0
Study 15951715 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 14616321 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalational anaesthesia (IA)
Number of subjects: 40
Study 14616321 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA)
Number of subjects: 40
Study 11119731 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral HRT (2 mg of estradiol on days 1-12, 2 mg of estradiol plus 1 mg of norethisterone acetate on days 13-22, and 1 mg of estradiol on days 23-28; n = 21)
Number of subjects: 42
Study 11119731 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal HRT (50 microg/d of estradiol on days 1-28 and 250 microg/d of norethisterone acetate on days 15-28; n = 21)
Number of subjects: 42
Study 9358693 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT with respiratory training (CBT‐R)
Number of subjects: 54
Study 9358693 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT without respiratory training (CBT)
Number of subjects: 54
Study 9358693 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (Control)
Number of subjects: 54
Study 8237812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0
Study 8237812 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 8237812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3777162 — intervention group
Group type: EXPERIMENTAL
Intervention: [2‐3H]‐ and [6‐3H]glucose given simultaneously
Number of subjects: 8
Study 3777162 — intervention group
Group type: COMPARATOR
Intervention: [3‐3H]glucose given
Number of subjects: 8
Study 3777162 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 8
Study 29125933 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid fixation with 4 L miniplates placed bilaterally in the maxilla after distraction device removal.
Number of subjects: 22
Study 29125933 — intervention group
Group type: COMPARATOR
Intervention: No miniplates placed after removing the distraction devices (control group).
Number of subjects: 22
Study 28277060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) with clopidogrel in addition to aspirin
Number of subjects: 165
Study 28277060 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 165
Study 25516635 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-weekly doses of nanoparticle albumin-bound paclitaxel
Number of subjects: 730
Study 25516635 — intervention group
Group type: EXPERIMENTAL
Intervention: weekly doses of nanoparticle albumin-bound paclitaxel
Number of subjects: 730
Study 25516635 — intervention group
Group type: COMPARATOR
Intervention: weekly doses of Cremophor-based paclitaxel
Number of subjects: 730
Study 25945213 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-intervention (TI)
Number of subjects: 27
Study 25945213 — intervention group
Group type: COMPARATOR
Intervention: Traditional in-person home visits
Number of subjects: 27
Study 21949754 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy
Number of subjects: 83
Study 18640467 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination lidocaine 20 mg and dexamethasone 6 mg
Number of subjects: 140
Study 18640467 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 20 mg
Number of subjects: 140
Study 18640467 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 6 mg
Number of subjects: 140
Study 17031284 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 0
Study 17031284 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 14526299 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg of oral misoprostol every 8 hours
Number of subjects: 43
Study 14526299 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 microg of vaginal misoprostol every 8 hours
Number of subjects: 43
Study 14526299 — intervention group
Group type: COMPARATOR
Intervention: 400 microg vaginally every 12 hours (historic control)
Number of subjects: 43
Study 14526299 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (oral and vaginal misoprostol)
Number of subjects: 43
Study 10651190 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lomefloxacin 0.3%
Number of subjects: 40
Study 10651190 — intervention group
Group type: COMPARATOR
Intervention: Topical ofloxacin 0.3%
Number of subjects: 40
Study 8952750 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA treatment
Number of subjects: 50
Study 8952750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 1751898 — intervention group
Group type: EXPERIMENTAL
Intervention: Lachman test
Number of subjects: 0
Study 1751898 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior drawer test
Number of subjects: 0
Study 1751898 — intervention group
Group type: COMPARATOR
Intervention: KT1000 knee arthrometer
Number of subjects: 0
Study 1751898 — intervention group
Group type: EXPERIMENTAL
Intervention: Jerk test
Number of subjects: 0
Study 6802100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate (20 mg) after pimozide pretreatment (5 weeks)
Number of subjects: 30
Study 6802100 — intervention group
Group type: COMPARATOR
Intervention: Dextroamphetamine sulfate (20 mg) after placebo pretreatment
Number of subjects: 30
Study 6802100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate (20 mg) after pimozide pretreatment
Number of subjects: 30
Study 6802100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate (20 mg)
Number of subjects: 30
Study 30507214 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) anger-reduction treatment for 12 weeks
Number of subjects: 158
Study 30507214 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 158
Study 29241450 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 262
Study 29241450 — intervention group
Group type: COMPARATOR
Intervention: Conventional care regimens (CCR)
Number of subjects: 262
Study 29241450 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cytarabine
Number of subjects: 262
Study 26409603 — intervention group
Group type: EXPERIMENTAL
Intervention: ERCP-first approach
Number of subjects: 257
Study 26409603 — intervention group
Group type: COMPARATOR
Intervention: MRCP-first approach
Number of subjects: 257
Study 23340248 — intervention group
Group type: COMPARATOR
Intervention: 0 g polydextrose (control)
Number of subjects: 21
Study 23340248 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.3 g polydextrose
Number of subjects: 21
Study 23340248 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 g polydextrose
Number of subjects: 21
Study 23340248 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g polydextrose
Number of subjects: 21
Study 23340248 — intervention group
Group type: COMPARATOR
Intervention: Control preload
Number of subjects: 21
Study 21079110 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended arm (evidence-based practice bundle including omission of mechanical bowel preparation, preoperative and intraoperative warming, supplemental oxygen, intraoperative intravenous fluid restriction, use of a surgical wound protector)
Number of subjects: 197
Study 21079110 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (current practice)
Number of subjects: 197
Study 21079110 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended arm
Number of subjects: 197
Study 21079110 — intervention group
Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 197
Study 19936217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA-PQP)
Number of subjects: 1553
Study 19936217 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 1553
Study 17680178 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin anticoagulation at 180 U x kg(‐1) plus 3000 U every 30 min for OPCAB patients, along with rectal aspirin 650 mg during the procedure.
Number of subjects: 197
Study 17680178 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin anticoagulation regimen in OPCAB patients.
Number of subjects: 197
Study 17680178 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin and protamine doses in OPCAB group.
Number of subjects: 197
Study 17680178 — intervention group
Group type: COMPARATOR
Intervention: OPCAB group outcomes.
Number of subjects: 197
Study 14986215 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual distraction and patient-controlled sedation (PCS)
Number of subjects: 165
Study 14986215 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual distraction and patient-controlled sedation (PCS)
Number of subjects: 165
Study 14986215 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled sedation (PCS) alone
Number of subjects: 165
Study 11461729 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 French catheters
Number of subjects: 400
Study 11461729 — intervention group
Group type: COMPARATOR
Intervention: 6 French catheters
Number of subjects: 400
Study 10806855 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous rhEpo 150 U/kg.time, three times a week for 6 weeks
Number of subjects: 45
Study 10806855 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous rhEpo 250 U/kg.time, three times a week for 6 weeks
Number of subjects: 45
Study 10806855 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 45